Medical/Pharmaceuticals News & Press Release Distribution

ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer

SOUTH SAN FRANCISCO, Calif., July 1, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment ofPaul August, Ph.D., as the Chief Scientific Officer. "We are thrilled to welcome Dr. August to our team," s...

2022-07-01 22:00 4870

GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia

Building public trust and educating on the importance of getting vaccinated KUALA LUMPUR, Malaysia, July 1, 2022 /PRNewswire/ -- GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, technology an...

2022-07-01 09:16 2874

GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia

Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS

GOTHENBURG, Sweden, July 1, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) ("Mentice") Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on9th June 2022, now has been completed. The information was submitted for re...

2022-07-01 03:42 2473

Tencent Cloud and Millennium Technology Services Roll Out i-Care to Connect Patients, Families and Caregivers, Delivering Seamless Comfort Care Anytime, Anywhere

The Tencent Cloud-backed solution aims to help improve patients' experience and quality of life SINGAPORE, June 30, 2022 /PRNewswire/ -- Customers' habits and expectations have evolved dramatically over the last few years across various industries including the medical and healthcare field, driv...

2022-06-30 22:00 4304

Tencent Cloud and Millennium Technology Services Roll Out i-Care to Connect Patients, Families and Caregivers, Delivering Seamless Comfort Care Anytime, Anywhere

Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover

HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...

2022-06-30 20:43 3877

Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover

HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...

2022-06-30 20:16 3690

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

- Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend treatmen...

2022-06-30 19:00 2063

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK

MELBOURNE, Australia, June 30, 2022 /PRNewswire/ -- UK consumers will again be able to buy VIRALEZE™, an easy-to-use barrier nasal spray, from LloydsPharmacy, following its relaunch online, with instore availability to follow shortly. Extensive antiviral testing undertaken at the globally renowne...

2022-06-30 12:41 1363

DigiconAsia readers honor Asia Pacific's digital innovators

The inaugural DigiconAsia DX Solution Excellence Awards honors Asia Pacific's digital innovators for providing transformative solutions and services across various industry sectors. SINGAPORE, June 30, 2022 /PRNewswire/ -- Over the...

2022-06-30 12:00 2765

DigiconAsia readers honor Asia Pacific's digital innovators

Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918

SUZHOU, China and ROCKVILLE, Md., June 29, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its novel inhibitor of the embryonic ectoderm...

2022-06-30 10:41 1523

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan

SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabi...

2022-06-30 08:00 2552

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan

Insurance providers can assess customer health risks in real-time using contactless vital sign monitoring solution from NuraLogix

LAS VEGAS, June 29, 2022 /PRNewswire/ -- Insurance providers are now able to evaluate customer health risks in real-time using a revolutionary contactless wellness and vital sign monitoring solution fromNuraLogix. The application allows insurance providers to quickly perform a customer health ...

2022-06-29 21:05 2236

Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China

* Globally first dual immune checkpoint inhibitor bi-specific antibody approved for marketing * China's first immunotherapy bi-specific antibody approved for marketing * A phase III trial of Cadonilimab combined with platinum-based chemotherapy +/- bevacizumab for the first-line treatment ...

2022-06-29 20:14 1771

BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures

NEW YORK, June 29, 2022 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client,BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement withGenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company b...

2022-06-29 20:00 2358

Positive data from the clinical phase I MAD study with AlzeCure's Alzheimer's project NeuroRestore ACD856

STOCKHOLM, June 29, 2022 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced th...

2022-06-29 19:32 1526

Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution

SEOUL, South Korea, June 29, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible with the company's fully automated 'AIOS' (All-in-One System). This is ...

2022-06-29 19:00 1745

Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic

GOTHENBURG, Sweden, June 29, 2022 /PRNewswire/ -- Mentice, Gothenburg (STO: MNTC), a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic,Dublin (NYSE: MDT), a global healthcare technology leader, has signed an agreement to acquire Mentice...

2022-06-29 14:37 1297

Supporting Communities and Sharing Happiness, 28 Liberty Successfully Hosts Multiple Community Events at New York's Fosun Plaza

NEW YORK, June 28, 2022 /PRNewswire/ -- As the summer arrives, New Yorkers have been enjoying their favorite season in the year. Starting from early June, in just 3 weeks, Fosun's 28 Liberty has successfully hosted multiple community events at Fosun Plaza with thousands of participants, in suppor...

2022-06-29 09:00 1573

Supporting Communities and Sharing Happiness, 28 Liberty Successfully Hosts Multiple Community Events at New York's Fosun Plaza

Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential Skin Ltd , a leading skin genomics start-up, has been awarded anInnovate UK SMART Grant to fund a project on advancing current understanding of ...

2022-06-29 08:32 1836

Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward

Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications

SAN FRANCISCO and SUZHOU, China, June 29, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-29 08:00 2218